CAMG
RANI icon

CWA Asset Management Group’s Rani Therapeutics RANI Stock Holding History

CWA Asset Management Group’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Hold
150,000
– – ﹤0.01% 687
2026
Q1 		$110K Hold
150,000
– – ﹤0.01% 640
2025
Q4 		$203K Hold
150,000
– – 0.01% 622
2025
Q3 		$75K Buy
150,000
+66,667
+80% +$34.7K ﹤0.01% 651
2025
Q2 		$42.8K Hold
83,333
– – ﹤0.01% 631
2025
Q1 		$105K Buy
+83,333
New +$123K 0.01% 588

Other funds holding RANI

KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
WDL
Well Done LLC Holland, Michigan $743M AUM 22.58% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CWA Asset Management Group's RANI Position: Q2 2026 in Review

CWA Asset Management Group held its Rani Therapeutics (RANI) position steady in Q2 2026 at 150,000 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

CWA Asset Management Group first reported a position in RANI in Q1 2025 and has held it in 6 quarters since. The position peaked at $203K in Q4 2025. 13 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • CWA Asset Management Group held 150,000 shares of Rani Therapeutics worth $114K as of Q2 2026.
  • CWA Asset Management Group left its Rani Therapeutics share count unchanged in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #687 holding.
  • CWA Asset Management Group first reported a position in Rani Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • CWA Asset Management Group's Rani Therapeutics position peaked at $203K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.